You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Preleukemia

Showing 76 - 100 of 1,392
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Relapsed, Myeloid Trial in Netherlands, Switzerland (MP0533 (multispecific DARPin CD3 Engager Targeting CD33, CD123

Recruiting
  • Leukemia
  • +3 more
  • MP0533 (multispecific DARPin CD3 Engager Targeting CD33, CD123 and CD70)
  • Amsterdam, Netherlands
  • +4 more
Jan 4, 2023

High Risk Myelodysplastic Syndrome, IPSS Risk Category Intermediate-1, Myelodysplastic Syndrome Trial in Houston (Azacitidine,

Active, not recruiting
Has Results
  • High Risk Myelodysplastic Syndrome
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Acute Myeloid Leukemia, MDS Trial in Bronx (Venetoclax Oral Tablet, Daunorubicin, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Venetoclax Oral Tablet
  • +2 more
  • Bronx, New York
    Montefiore Einstein Cancer Center
Jul 14, 2022

Leukemia, Acute, AML, Adult, ALL, Adult Trial in Charlottesville (Palliative Care Visits)

Recruiting
  • Leukemia, Acute
  • +3 more
  • Palliative Care Visits
  • Charlottesville, Virginia
    University of Virginia
Apr 28, 2022

Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial (UAE Inhibitor TAK-243)

Not yet recruiting
  • Myelodysplastic Syndrome
  • +4 more
  • UAE Inhibitor TAK-243
  • (no location specified)
Oct 20, 2022

MDS, Chronic Myelomonocytic Leukemia-2, Secondary Acute Myeloid Leukemia Trial in Nanjing (unrelated umbilical cord blood)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • unrelated umbilical cord blood
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Oct 16, 2022

Acute Myeloid Leukemia, MDS Trial in Rochester (Inpatient serious illness care program)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Inpatient serious illness care program
  • Rochester, New York
    University of Rochester
Jun 21, 2022

Secondary Myelodysplastic Syndrome, Therapy-Related Myelodysplastic Syndrome Trial in Columbus (Azacitidine, Quality-of-Life

Recruiting
  • Secondary Myelodysplastic Syndrome
  • Therapy-Related Myelodysplastic Syndrome
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 1, 2022

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)

Completed
  • Chronic Myeloproliferative Disorders
  • +5 more
  • sargramostim
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 3, 2022

Drug/Agent Toxicity by Tissue/Organ, Leukemia, MDS Trial in Chicago, Kankakee (amifostine trihydrate, cytarabine, mitoxantrone

Withdrawn
  • Drug/Agent Toxicity by Tissue/Organ
  • +3 more
  • amifostine trihydrate
  • +2 more
  • Chicago, Illinois
  • +3 more
Jan 31, 2023

Relapsed Acute Myeloid Leukemia Trial in Saint Louis (Flotetuzumab, Donor lymphocyte infusion)

Recruiting
  • Relapsed Acute Myeloid Leukemia
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 7, 2022

Minimal Residual Disease of Acute Myelogenous Leukemia or High

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
    • Rochester, New York
      University of Rochester Medical Center
    May 3, 2022

    Analyze Occurrence of Transformation From Myelodysplastic

    Completed
    • Myelodysplastic Syndromes
    • Leukemia, Myeloid, Acute
      • Kobe, Hyogo, Japan
        Shinko Hospital
      Jun 13, 2022

      Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation Trial in Wuhan

      Recruiting
      • Acute Myeloid Leukemia, Adult
      • +2 more
      • Fludarabine and Busulfan
      • Fludarabine and Melphalan
      • Wuhan, Hubei, China
        Wuhan Union Hospital, Tongji Medical college, Huazhong Universit
      Jan 5, 2023

      Myelodysplastic Syndrome Trial in New York (Revlimid (Lenalidomide))

      Active, not recruiting
      Has Results
      • Myelodysplastic Syndrome
      • Revlimid (Lenalidomide)
      • New York, New York
        Columbia University Medical Center
      Jan 12, 2022

      Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Baltimore (Azacitidine, Sargramostim)

      Completed
      Has Results
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndrome
      • Baltimore, Maryland
        The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      Sep 23, 2022

      Leukemia Trial in Houston (Cladribine, Cytarabine, Decitabine)

      Recruiting
      • Leukemia
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Aug 23, 2022

      Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Myelodysplastic Syndrome Trial in Zhengzhou (6MW3211

      Not yet recruiting
      • Acute Myeloid Leukemia, in Relapse
      • +2 more
      • 6MW3211 injection with Intravenous Infusion
      • Zhengzhou, Henan, China
        Henan Cancer Hospital
      Jul 2, 2022

      Myeloid Malignancy, MDS, Myelofibrosis Trial in Boston (Navitoclax, Venetoclax, Decitabine)

      Recruiting
      • Myeloid Malignancy
      • +4 more
      • Boston, Massachusetts
      • +2 more
      Jul 21, 2022

      Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,

      Recruiting
      • Acute Myeloid Leukemia
      • +4 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 27, 2023

      AML, MDS Trial in Tianjin (SHR-1702)

      Active, not recruiting
      • AML
      • MDS
      • Tianjin, Tianjin, China
        Blood disease hospital of Chinese Academy of Medical Sciences
      Mar 7, 2022

      High Risk Myelodysplastic Syndrome Trial in Houston (Guadecitabine)

      Active, not recruiting
      • High Risk Myelodysplastic Syndrome
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 2, 2022

      MDS, MDS Trial in Tampa, Boston, Houston (APR-548 + Azacitidine)

      Terminated
      • MDS
      • Myelodysplastic Syndromes
      • APR-548 + Azacitidine
      • Tampa, Florida
      • +3 more
      Jul 20, 2022

      Cancer, MDS-EB, MDS Trial in Athens, Southampton, Sheffield (INKmune)

      Recruiting
      • Cancer
      • +4 more
      • INKmune
      • Athens, Attiki, Greece
      • +2 more
      Jul 3, 2023

      Myelodysplasia, Hematologic Malignancy Trial in Columbus (CliniMACS® TCRaß/CD19 Combined Depletion System)

      Recruiting
      • Myelodysplasia
      • Hematologic Malignancy
      • CliniMACS® TCRαβ/CD19 Combined Depletion System
      • Columbus, Ohio
        Nationwide Children's Hospital
      Jan 11, 2022